Cancers, Vol. 11, Pages 41: Epilepsy Associates with Decreased HIF-1α/STAT5b Signaling in Glioblastoma

Cancers, Vol. 11, Pages 41: Epilepsy Associates with Decreased HIF-1α/STAT5b Signaling in Glioblastoma

Cancers doi: 10.3390/cancers11010041

Authors: Sharon Berendsen Wim G. M. Spliet Marjolein Geurts Wim Van Hecke Tatjana Seute Tom J. Snijders Vincent Bours Erica H. Bell Arnab Chakravarti Pierre A. Robe

Epilepsy at presentation is an independent favorable prognostic factor in glioblastoma (GBM). In this study, we analyze the oncologic signaling pathways that associate with epilepsy in human GBMs, and that can underlie this prognostic effect. Following ethical approval and patient consent, fresh frozen GBM tissue was obtained from 76 patient surgeries. Hospital records were screened for the presence of seizures at presentation of the disease. mRNA and miRNA expression-based and gene set enrichment analyses were performed on these tissues, to uncover candidate oncologic pathways that associate with epilepsy. We performed qPCR experiments and immunohistochemistry on tissue microarrays containing 286 GBMs to further explore the association of these candidate pathways and of markers of mesenchymal transformation (NF-κB, CEBP-β, STAT3, STAT5b, VEGFA, SRF) with epilepsy. Gene sets involved in hypoxia/HIF-1α, STAT5, CEBP-β and epithelial-mesenchymal transformation signaling were significantly downregulated in epileptogenic GBMs. On confirmatory protein expression analyses, epileptogenic tumors were characterized by a significant downregulation of phospho-STAT5b, a target of HIF-1α. Epilepsy status did not associate with molecular subclassification or miRNA expression patterns of the tumors. Epileptogenic GBMs correlate with decreased hypoxia/ HIF-1α/STAT5b signaling compared to glioblastomas that do not present with epilepsy.

http://bit.ly/2RB8ErO